 Anna Furniss
Concepts (214)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Papillomavirus Vaccines | 4 | 2024 | 223 | 0.560 |
Why?
| | Vaccination | 9 | 2024 | 1205 | 0.560 |
Why?
| | Overweight | 5 | 2023 | 471 | 0.440 |
Why?
| | Turner Syndrome | 2 | 2023 | 44 | 0.410 |
Why?
| | Reminder Systems | 3 | 2016 | 162 | 0.340 |
Why?
| | Text Messaging | 3 | 2016 | 154 | 0.330 |
Why?
| | Safety-net Providers | 2 | 2021 | 95 | 0.320 |
Why?
| | Papillomavirus Infections | 3 | 2024 | 262 | 0.310 |
Why?
| | Parents | 5 | 2022 | 1190 | 0.310 |
Why?
| | Weight Loss | 3 | 2017 | 642 | 0.290 |
Why?
| | Hypertension | 3 | 2022 | 1059 | 0.250 |
Why?
| | Obesity | 5 | 2023 | 2513 | 0.250 |
Why?
| | Weight Reduction Programs | 2 | 2017 | 94 | 0.250 |
Why?
| | Neurodevelopmental Disorders | 2 | 2021 | 109 | 0.210 |
Why?
| | Food Assistance | 1 | 2023 | 25 | 0.210 |
Why?
| | Postpartum Period | 2 | 2023 | 281 | 0.210 |
Why?
| | Healthcare Disparities | 2 | 2018 | 479 | 0.210 |
Why?
| | Genetic Linkage | 2 | 2022 | 297 | 0.200 |
Why?
| | Dental Caries | 1 | 2023 | 162 | 0.190 |
Why?
| | Gender Dysphoria | 1 | 2021 | 13 | 0.190 |
Why?
| | Klinefelter Syndrome | 1 | 2022 | 50 | 0.190 |
Why?
| | Adrenal Hyperplasia, Congenital | 1 | 2021 | 28 | 0.190 |
Why?
| | Disorders of Sex Development | 1 | 2021 | 35 | 0.190 |
Why?
| | Mood Disorders | 1 | 2021 | 112 | 0.180 |
Why?
| | Dyslipidemias | 1 | 2022 | 154 | 0.180 |
Why?
| | Feasibility Studies | 1 | 2023 | 737 | 0.180 |
Why?
| | Transgender Persons | 1 | 2022 | 134 | 0.170 |
Why?
| | Electronic Health Records | 2 | 2023 | 801 | 0.170 |
Why?
| | Liver Diseases | 1 | 2022 | 254 | 0.170 |
Why?
| | Chromosomes, Human, Pair 16 | 1 | 2019 | 30 | 0.160 |
Why?
| | Female | 26 | 2023 | 59507 | 0.160 |
Why?
| | Logistic Models | 5 | 2021 | 1843 | 0.160 |
Why?
| | Precision Medicine | 1 | 2022 | 338 | 0.150 |
Why?
| | Delayed Diagnosis | 1 | 2018 | 70 | 0.150 |
Why?
| | Genome-Wide Association Study | 2 | 2022 | 1197 | 0.150 |
Why?
| | Information Seeking Behavior | 1 | 2018 | 35 | 0.150 |
Why?
| | Osteoprotegerin | 1 | 2017 | 23 | 0.150 |
Why?
| | Adolescent | 12 | 2024 | 17808 | 0.150 |
Why?
| | Exome | 1 | 2019 | 200 | 0.150 |
Why?
| | Humans | 33 | 2024 | 114757 | 0.150 |
Why?
| | Cardiologists | 1 | 2017 | 40 | 0.150 |
Why?
| | Time-to-Treatment | 1 | 2018 | 147 | 0.140 |
Why?
| | Organizations, Nonprofit | 1 | 2017 | 17 | 0.140 |
Why?
| | Birth Order | 1 | 2017 | 12 | 0.140 |
Why?
| | Lost to Follow-Up | 1 | 2017 | 22 | 0.140 |
Why?
| | Parenting | 1 | 2020 | 251 | 0.140 |
Why?
| | Vaccines | 1 | 2022 | 375 | 0.140 |
Why?
| | Child | 11 | 2024 | 18352 | 0.140 |
Why?
| | Health Knowledge, Attitudes, Practice | 3 | 2022 | 1183 | 0.140 |
Why?
| | Population Density | 1 | 2017 | 94 | 0.140 |
Why?
| | Health Promotion | 3 | 2023 | 686 | 0.140 |
Why?
| | Genome, Human | 1 | 2019 | 351 | 0.140 |
Why?
| | Down Syndrome | 1 | 2021 | 338 | 0.140 |
Why?
| | Hearing Tests | 1 | 2017 | 51 | 0.140 |
Why?
| | Blood Pressure | 2 | 2022 | 1530 | 0.130 |
Why?
| | Patient Readmission | 1 | 2021 | 608 | 0.130 |
Why?
| | Renal Dialysis | 3 | 2009 | 369 | 0.130 |
Why?
| | Colorado | 6 | 2024 | 4086 | 0.130 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2019 | 440 | 0.130 |
Why?
| | Influenza, Human | 1 | 2021 | 546 | 0.130 |
Why?
| | Neonatal Screening | 1 | 2017 | 152 | 0.130 |
Why?
| | Aftercare | 1 | 2017 | 186 | 0.130 |
Why?
| | Anxiety | 1 | 2021 | 842 | 0.120 |
Why?
| | Clinical Decision-Making | 1 | 2017 | 268 | 0.120 |
Why?
| | Infant, Newborn | 6 | 2023 | 5035 | 0.120 |
Why?
| | Exercise Test | 1 | 2017 | 544 | 0.120 |
Why?
| | Adolescent Health Services | 1 | 2015 | 68 | 0.120 |
Why?
| | Odds Ratio | 3 | 2021 | 954 | 0.120 |
Why?
| | Needs Assessment | 1 | 2016 | 313 | 0.110 |
Why?
| | Hearing Loss | 1 | 2017 | 184 | 0.110 |
Why?
| | Genetic Variation | 1 | 2019 | 876 | 0.110 |
Why?
| | Cross-Sectional Studies | 5 | 2023 | 4409 | 0.110 |
Why?
| | Mental Disorders | 1 | 2021 | 889 | 0.110 |
Why?
| | Prediabetic State | 1 | 2016 | 220 | 0.110 |
Why?
| | Male | 17 | 2022 | 55579 | 0.110 |
Why?
| | Infant | 6 | 2023 | 7935 | 0.100 |
Why?
| | Risk Assessment | 1 | 2021 | 2973 | 0.100 |
Why?
| | Myocardium | 1 | 2017 | 908 | 0.100 |
Why?
| | Kidney Failure, Chronic | 2 | 2009 | 487 | 0.100 |
Why?
| | Poverty | 3 | 2023 | 442 | 0.100 |
Why?
| | Patient Compliance | 1 | 2016 | 525 | 0.100 |
Why?
| | Cardiovascular Diseases | 2 | 2022 | 1727 | 0.100 |
Why?
| | United States | 8 | 2022 | 12176 | 0.100 |
Why?
| | Propensity Score | 2 | 2021 | 224 | 0.090 |
Why?
| | Urban Health Services | 2 | 2021 | 60 | 0.090 |
Why?
| | Estradiol | 2 | 2023 | 455 | 0.090 |
Why?
| | Young Adult | 6 | 2023 | 10463 | 0.080 |
Why?
| | Adult | 10 | 2023 | 30548 | 0.080 |
Why?
| | Arteriovenous Shunt, Surgical | 1 | 2009 | 15 | 0.080 |
Why?
| | Catheters, Indwelling | 1 | 2009 | 79 | 0.080 |
Why?
| | Retrospective Studies | 7 | 2021 | 12515 | 0.080 |
Why?
| | Middle Aged | 10 | 2021 | 26757 | 0.070 |
Why?
| | Risk Factors | 5 | 2021 | 8627 | 0.070 |
Why?
| | Breast Neoplasms | 1 | 2018 | 1868 | 0.070 |
Why?
| | Child, Preschool | 4 | 2023 | 9079 | 0.070 |
Why?
| | Rural Population | 2 | 2021 | 446 | 0.070 |
Why?
| | Aged | 7 | 2021 | 19094 | 0.060 |
Why?
| | Peripheral Vascular Diseases | 1 | 2006 | 97 | 0.060 |
Why?
| | Minority Groups | 2 | 2018 | 227 | 0.060 |
Why?
| | Surveys and Questionnaires | 4 | 2018 | 4625 | 0.060 |
Why?
| | Time Factors | 4 | 2018 | 6124 | 0.060 |
Why?
| | Guatemala | 2 | 2016 | 266 | 0.060 |
Why?
| | Heart Failure | 1 | 2017 | 1952 | 0.060 |
Why?
| | Hospitals | 2 | 2021 | 580 | 0.060 |
Why?
| | Cohort Studies | 3 | 2022 | 4901 | 0.060 |
Why?
| | Follow-Up Studies | 4 | 2019 | 4420 | 0.060 |
Why?
| | Muscular Atrophy | 1 | 2005 | 78 | 0.060 |
Why?
| | Patient Acceptance of Health Care | 2 | 2022 | 680 | 0.060 |
Why?
| | Case-Control Studies | 2 | 2021 | 3005 | 0.060 |
Why?
| | Sleep Wake Disorders | 1 | 2007 | 233 | 0.060 |
Why?
| | Isometric Contraction | 1 | 2005 | 155 | 0.060 |
Why?
| | Dental Hygienists | 1 | 2023 | 12 | 0.050 |
Why?
| | Vaccination Coverage | 1 | 2024 | 63 | 0.050 |
Why?
| | Testosterone Congeners | 1 | 2022 | 7 | 0.050 |
Why?
| | Lower Extremity | 1 | 2005 | 335 | 0.050 |
Why?
| | Whole Genome Sequencing | 1 | 2022 | 94 | 0.050 |
Why?
| | Gonadotropin-Releasing Hormone | 1 | 2022 | 188 | 0.050 |
Why?
| | Linear Models | 2 | 2017 | 770 | 0.050 |
Why?
| | Liver Cirrhosis | 1 | 2022 | 228 | 0.040 |
Why?
| | Motor Activity | 1 | 2005 | 640 | 0.040 |
Why?
| | Child Behavior Disorders | 1 | 2021 | 131 | 0.040 |
Why?
| | Quality of Life | 2 | 2007 | 2358 | 0.040 |
Why?
| | Practice Patterns, Physicians' | 1 | 2007 | 1178 | 0.040 |
Why?
| | Recombinases | 1 | 2019 | 6 | 0.040 |
Why?
| | Testosterone | 1 | 2022 | 343 | 0.040 |
Why?
| | Mentors | 1 | 2020 | 156 | 0.040 |
Why?
| | Patient Care Team | 1 | 2023 | 517 | 0.040 |
Why?
| | Attitude | 1 | 2020 | 229 | 0.040 |
Why?
| | Developmental Disabilities | 1 | 2021 | 239 | 0.040 |
Why?
| | Pilot Projects | 1 | 2023 | 1370 | 0.040 |
Why?
| | RNA Splicing Factors | 1 | 2019 | 49 | 0.040 |
Why?
| | Pregnancy | 2 | 2021 | 5525 | 0.040 |
Why?
| | Mastectomy | 1 | 2018 | 99 | 0.040 |
Why?
| | Longitudinal Studies | 2 | 2020 | 2386 | 0.040 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2018 | 182 | 0.040 |
Why?
| | Mississippi | 1 | 2017 | 20 | 0.040 |
Why?
| | Nuclear Family | 1 | 2018 | 49 | 0.040 |
Why?
| | Rural Health Services | 1 | 2018 | 93 | 0.040 |
Why?
| | Altitude | 1 | 2021 | 433 | 0.040 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2018 | 333 | 0.040 |
Why?
| | Health Behavior | 1 | 2023 | 704 | 0.040 |
Why?
| | Alternative Splicing | 1 | 2019 | 188 | 0.040 |
Why?
| | Insurance Coverage | 1 | 2018 | 201 | 0.040 |
Why?
| | Emigration and Immigration | 1 | 2017 | 44 | 0.030 |
Why?
| | Maternal Age | 1 | 2017 | 117 | 0.030 |
Why?
| | Pediatricians | 1 | 2018 | 122 | 0.030 |
Why?
| | Sex Distribution | 1 | 2017 | 335 | 0.030 |
Why?
| | Databases, Factual | 1 | 2021 | 1128 | 0.030 |
Why?
| | Algorithms | 1 | 2023 | 1468 | 0.030 |
Why?
| | Obstetrics | 1 | 2018 | 146 | 0.030 |
Why?
| | Income | 1 | 2017 | 167 | 0.030 |
Why?
| | Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2016 | 25 | 0.030 |
Why?
| | Peru | 1 | 2016 | 54 | 0.030 |
Why?
| | Haemophilus Vaccines | 1 | 2016 | 27 | 0.030 |
Why?
| | Phenotype | 1 | 2023 | 2812 | 0.030 |
Why?
| | Diabetes Complications | 1 | 2017 | 211 | 0.030 |
Why?
| | Measles-Mumps-Rubella Vaccine | 1 | 2016 | 41 | 0.030 |
Why?
| | Prognosis | 3 | 2009 | 3334 | 0.030 |
Why?
| | Muscle, Skeletal | 1 | 2005 | 1472 | 0.030 |
Why?
| | Hepatitis B Vaccines | 1 | 2016 | 46 | 0.030 |
Why?
| | Appointments and Schedules | 1 | 2016 | 73 | 0.030 |
Why?
| | Rotavirus Vaccines | 1 | 2016 | 48 | 0.030 |
Why?
| | Pandemics | 1 | 2024 | 1319 | 0.030 |
Why?
| | Intention to Treat Analysis | 1 | 2015 | 68 | 0.030 |
Why?
| | Immunization | 1 | 2018 | 401 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2018 | 1176 | 0.030 |
Why?
| | Aging | 1 | 2005 | 1620 | 0.030 |
Why?
| | Insurance, Health | 1 | 2017 | 244 | 0.030 |
Why?
| | Educational Status | 1 | 2017 | 412 | 0.030 |
Why?
| | Women's Health | 1 | 2017 | 271 | 0.030 |
Why?
| | Cell Phone | 1 | 2016 | 76 | 0.030 |
Why?
| | Stroke Volume | 1 | 2017 | 508 | 0.030 |
Why?
| | Echocardiography | 1 | 2017 | 554 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2018 | 1078 | 0.030 |
Why?
| | Urban Population | 1 | 2017 | 398 | 0.030 |
Why?
| | Immunization Schedule | 1 | 2016 | 184 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2022 | 1892 | 0.030 |
Why?
| | Ventricular Function, Left | 1 | 2017 | 467 | 0.030 |
Why?
| | Body Mass Index | 2 | 2016 | 1958 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1435 | 0.030 |
Why?
| | Immunization Programs | 1 | 2016 | 205 | 0.030 |
Why?
| | Sexual Behavior | 1 | 2018 | 440 | 0.030 |
Why?
| | Caregivers | 1 | 2020 | 717 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2022 | 2099 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2017 | 479 | 0.030 |
Why?
| | Medicaid | 1 | 2017 | 407 | 0.030 |
Why?
| | Guideline Adherence | 1 | 2017 | 490 | 0.030 |
Why?
| | Vascular Stiffness | 1 | 2017 | 407 | 0.030 |
Why?
| | Exercise | 1 | 2023 | 1644 | 0.030 |
Why?
| | Heart Ventricles | 1 | 2017 | 709 | 0.030 |
Why?
| | Sex Factors | 1 | 2017 | 1717 | 0.030 |
Why?
| | Program Evaluation | 1 | 2016 | 822 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 1691 | 0.020 |
Why?
| | Decision Making | 1 | 2018 | 781 | 0.020 |
Why?
| | Cognition | 1 | 2018 | 989 | 0.020 |
Why?
| | Mothers | 1 | 2016 | 651 | 0.020 |
Why?
| | Smoking | 1 | 2017 | 1384 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2017 | 1393 | 0.020 |
Why?
| | Confidence Intervals | 1 | 2009 | 309 | 0.020 |
Why?
| | Japan | 1 | 2007 | 87 | 0.020 |
Why?
| | Europe | 1 | 2007 | 336 | 0.020 |
Why?
| | Health Surveys | 1 | 2007 | 443 | 0.020 |
Why?
| | Survival Rate | 1 | 2009 | 1642 | 0.020 |
Why?
| | Electric Impedance | 1 | 2005 | 100 | 0.010 |
Why?
| | Kidney Diseases | 1 | 2007 | 350 | 0.010 |
Why?
| | Survival Analysis | 1 | 2006 | 1218 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2007 | 1796 | 0.010 |
Why?
| | Gait | 1 | 2005 | 249 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2016 | 9089 | 0.010 |
Why?
| | Adipose Tissue | 1 | 2005 | 539 | 0.010 |
Why?
| | Body Composition | 1 | 2005 | 592 | 0.010 |
Why?
| | Walking | 1 | 2005 | 422 | 0.010 |
Why?
| | Prevalence | 1 | 2006 | 2249 | 0.010 |
Why?
| | Hospitalization | 1 | 2006 | 1752 | 0.010 |
Why?
|
|
Furniss's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|